Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?

Journal of Gastroenterology

Volumn 42, Issue 4, 2007, Pages 275-278

  Hashimoto, Hiroshi ^a   Kushikata, Tetsuya ^a   Kudo, Mihoko ^a   Hirota, Kazuyoshi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Gastric acidity; H2 receptor antagonists; Proton pump inhibitors; Tolerance

Indexed keywords

DIAZEPAM; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; ROXATIDINE; TRIAZOLAM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; ASPIRATION PNEUMONIA; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; LONG TERM CARE; MALE; MONOTHERAPY; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH; STOMACH VOLUME; SURGICAL PATIENT; TREATMENT DURATION;

DRUG TOLERANCE; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; PNEUMONIA, ASPIRATION; PROTON PUMPS; TIME FACTORS;

EID: 34247616138     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1946-3     Document Type: Article

References (18)

1. KP Steinberg 2002 Stress-related mucosal disease in the critically ill patient: Risk factors and strategies to prevent stress-related bleeding in the intensive care unit Crit Care Med 30 Suppl S362-4 12072662 10.1097/00003246-200206001-00005
2. 2 antagonists for acid aspiration pneumonia prophylaxis. Is there evidence of tolerance? Br J Anaesth 90 576-9 12697583 10.1093/bja/aeg065 1:STN:280:DC%2BD3s7nvVGjsw%3D%3D
3. 2 antagonists reduces preanaesthetic efficacy for acid aspiration pneumonia prophylaxis in anaesthesia patients Can J Anesth 52 166-71 15684257
4. S Hurlimann B Abbühl W Inauen F Halter 1994 Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole Aliment Pharmacol Ther 8 193-201 8038351 1:CAS:528:DyaK2cXlslShsro%3D
5. P Netzer C Gaia M Sandoz T Huluk A Gut F Halter 1999 Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours Am J Gastroenterol 94 351-7 10022628 1:CAS:528:DyaK1MXhtlSjsLo%3D
6. 2 antagonist therapy Anesth Analg 101 1038-41 16192516 10.1213/ 01.ane.0000166979.99225.a0 1:CAS:528:DC%2BD2MXhtVeqsrrE
7. GJ Dockray 1999 Topical review. Gastrin and gastric epithelial physiology J Physiol 518 315-24 10381581 10.1111/ j.1469-7793.1999.0315p.x 1:CAS:528:DyaK1MXmtVWgsbY%3D
8. G Qvigstad JS Arnestad E Brenna HL Waldum 1998 Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori -negative patients Scand J Gastroenterol 33 1244-8 9930386 10.1080/00365529850172313 1:CAS:528:DyaK1MXmvVWntg%3D%3D
9. S Sanduleanu M Stridsberg D Jonkers W Hameeteman I Biemond G Lundqvist C Lamers 1999 Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: A case-control study Aliment Pharmacol Ther 13 145-53 10102943 10.1046/j.1365-2036.1999.00466.x 1:CAS:528:DyaK1MXitVeksbk%3D
10. M Robinson 1999 Review article: Current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia Aliment Pharmacol Ther 13 Suppl 5 5-10 10555603 10.1046/j.1365-2036.1999.00033.x
11. A el-Nujumi C Williams JE Ardill K Oien KE McColl 1998 Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment Gut 42 159-65 9536937 1:CAS:528:DyaK1cXhvVyht74%3D
12. KD Bardhan P Cherian AE Bishop JM Polak H Romanska MJ Perry 2001 Pantoprazole therapy in the long-term management of severe acid peptic disease: Clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies Am J Gastroenterol 96 1767-76 11419827 10.1111/j.1572-0241.2001.03185.x 1:CAS:528:DC%2BD3MXltFOgsrc%3D
13. T Konagaya M Bernsand P Norlen R Hakanson 2001 Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats Br J Pharmacol 133 37-42 11325792 10.1038/sj.bjp.0704037 1:CAS:528:DC%2BD3MXjs1aisro%3D
14. S Nakamura H Watanabe T Yokota H Matsui M Onji K Maeyama 2000 Effect of rabeprazole on histamine synthesis in enterochromaffin-like cells of mast cell-deficient (Ws/Ws) rats Eur J Pharmacol 394 9-16 10771028 10.1016/S0014-2999(00)00080-7 1:CAS:528:DC%2BD3cXisFKjsL0%3D
15. T Furuta N Shirai M Sugimoto A Nakamura A Hishida T Ishizaki 2005 Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies Drug Metab Pharmacokinet 20 153-67 15988117 10.2133/dmpk.20.153 1:CAS:528:DC%2BD2MXoslGmtbo%3D
16. RB Roberts MA Shirley 1974 Reducing the risk of acid aspiration during cesarean section Anesth Analg 53 859-68 4473928 1:STN:280:CSqD2M3otFw%3D
17. PE Haavik E Søreide B Hofstad PA Steen 1992 Does preoperative anxiety influence gastric fluid volume and acidity? Anesth Analg 75 91-4 1535490 10.1213/00000539-199207000-00017 1:STN:280:By2A3M3ovVI%3D
18. C Rosenstock J Møller A Hauberg 2001 Complaints related to respiratory events in anaesthesia and intensive care medicine from 1994 to 1998 in Denmark Acta Anaesthesiol Scand 45 53-8 11152034 10.1034/ j.1399-6576.2001.450109.x 1:STN:280:DC%2BD3M7ksF2htA%3D%3D